{"id":"W4205565447","doi":"10.1200/jco.2022.40.4_suppl.379","title":"Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":400,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Regimen; Confidence interval; Internal medicine; Clinical endpoint; Gastroenterology; Phases of clinical research; Randomized controlled trial; Surgery; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759987,0.001389985,0.002252295,0.0004095142,0.0005320373,0.001094273,0.001104211,0.001176201,0.004668075],"category_scores_gemma":[0.001116351,0.00073713,0.001575718,0.0004546173,0.001089288,0.0009818517,0.0004661946,0.003048343,0.0009480181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001400937,"about_ca_system_score_gemma":0.002557457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001926155,"about_ca_topic_score_gemma":0.005988417,"domain_scores_codex":[0.9994784,0.0002697037,0.00002012691,0.00008658529,0.00003625477,0.0001089747],"domain_scores_gemma":[0.9988287,0.0001853355,0.00019981,0.00008861587,0.000053389,0.0006441806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9488856,0.02744556,0.001847304,0.0002398413,0.0007258894,0.00006438126,0.0001025287,0.0005056573,0.006169839,0.00008287423,0.001220101,0.01271045],"study_design_scores_gemma":[0.8647425,0.1291185,0.003814616,0.00001003016,0.0003131521,0.0000651265,0.00003484202,0.0005273347,0.0006675673,0.0000923821,0.0005960853,0.00001773286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926696,0.001169486,0.0003499722,0.000370153,0.0001583106,0.00300854,0.00107532,0.00009126785,0.001107233],"genre_scores_gemma":[0.990647,0.0008010198,0.0012677,0.0008176384,0.000190433,0.003184464,0.001346782,0.0000253163,0.001719584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004668075,"threshold_uncertainty_score":0.0156163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1091740756274381,"score_gpt":0.4319048826952656,"score_spread":0.3227308070678275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}